Ljupco/iStock via Getty Images Investment Thesis LifeMD, Inc. (NASDAQ:LFMD) reported a mixed Q2 2024 earnings result and guidance. Management states that its non-core asset, WorkSimpli, had some mishaps in Q2, but these aspects are now behind themselves. And yet, this was the same narrative that they provided last quarter. Consequently, I now believe that WorkSimpli has no value. Or better put, I award it no value, as I do not believe management has any ability to monetize its WorkSimpli asset. If LifeMD to ...

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September: H.C. Wainwright 26th Annual Global Investment Conference, September 9-11 at the Lotte New York Palace Hotel. Management will deliver a corporate presentation on Monday, September 9th at 12:00 p.m. Eastern time and will hold one-on-one meetings with investors.TD C ...

LifeMD: Investor Presentation August 2024 NASDAQ: LFMD 9:41 "| ~ ■ LifeMD: = Schedule your appointment Today Tomorrow ASAP Jan 23 Jan 24 ~20 min wait Dr. Jennell Giles f Any available provider 十 Schedule an appointment Possible conditions: Middle ear infection Strong evidence Inflamation of external ear Important cautions regarding forward-looking statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the S ...

LifeMD, Inc. (NASDAQ:LFMD) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Officer Conference Call Participants David Larsen – BTIG Steve Dechert – KeyBanc William Wood – B. Riley Securities Sarah James – Cantor Yi Chen – H.C. Wainwright Alex Fuhrman – Craig-Hallum Capital Group Ilya Zubkov – Freedom Broker Operator Good afternoon. Thank you for joining us today to discuss LifeMD’s Results ...

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -46.15%. A quarter ago, it was expected that this company would post a loss of $0.13 per share when it actually produced a loss of $0.19, delivering a surprise of -46.15%.Over the last four quarters, the company has surpassed ...

虚拟医疗保健服务 - 公司的虚拟主要医疗保健服务LifeMD PC提供7x24小时高质量医疗服务[192] - 公司的订阅收入占总收入的97%[188] - 与ASCEND Therapeutics达成合作协议，为其提供整合的远程医疗服务以改善对EstroGel®的访问[200] - 与Medifast达成合作,利用公司的虚拟护理技术平台为其客户提供临床支持的体重管理计划,包括GLP-1药物,Medifast将向公司支付1000万美元[201] - 2024年第二季度总收入为5.07亿美元,同比增长41%,其中远程医疗收入占74.89%,同比增长67%[207] - 2024年第二季度毛利率为90.08%,远程医疗毛利率为88%[209] - 总收入增长37%，达到9.48亿美元，其中远程医疗收入增长60%，占总收入的72%[216] - 毛利率提高至89.85%，较上年同期的87.31%有所提升[219] 健康管理产品 - 公司推出了快速增长的GLP-1体重管理项目，自推出以来已有超过6万名患者订阅[193] - 公司的男性健康品牌RexMD自推出以来已服务约55.4万名客户和患者，获得4.6星Trustpilot评分[195] - 公司的女性皮肤健康品牌NavaMD利用专利技术和配方提供皮肤护理服务[197] - 公司的过敏和哮喘品牌Cleared提供低于同类品牌50%的价格的过敏和哮喘治疗服务[198] - 与Medifast的子公司Jason Pharmaceuticals签订股票购买协议和注册权协议,发行122.4425万股普通股,获得约1000万美元[202] 软件服务 - 公司的软件子公司WorkSimpli提供100%经常性收入的PDF文档转换、编辑和签名服务[188] - 子公司WorkSimpli在全球排名前25,000位,拥有超过5600万注册用户,已为客户转换或编辑了276TB的文档,截至2024年6月30日拥有超过15.8万活跃订阅[204] - 2024年第二季度WorkSimpli毛利率为96%[209] 财务情况 - 2024年第二季度销售和营销费用增加35%,主要用于推动LifeMD主要护理业务的销售增长[210] - 2024年第二季度一般和行政费用增加53%,主要包括股份支付费用增加、薪酬成本增加、商户手续费增加和法律专业费用增加[211] - 销售和营销费用增加39%，达到5.06亿美元，主要用于拓展远程医疗业务[220] - 一般及行政费用增加49%，达到3.38亿美元，主要包括股份支付费用、法律咨询费用和商户手续费的增加[221] - 研发费用增加75%，达到4,489,822美元，主要用于技术平台改进和摊销[224] - 经营活动产生的现金流入增加380%，达到9,741,922美元[229] - 投资活动现金流出增加29%，达到5,322,293美元，主要用于软件开发资本化[231] - 融资活动现金流出1,863,139美元，主要用于支付优先股股息和偿还贷款[232] 资金来源 - 公司主要通过产品销售、发行普通股和优先股、贷款和垫款等方式为运营提供资金[233] - 公司与Medifast达成合作,Medifast将向公司支付1000万美元以支持合作[234] - 公司与Medifast的子公司Jason Pharmaceuticals签订股票购买协议,以每股8.1671美元的价格发行122.4425万股普通股,获得约1000万美元[235] - 公司与Avenue签订信贷协议,获得最高4000万美元的可转换担保贷款额度,用于偿还公司的未偿还票据并用于一般公司用途[236] - Avenue已将100万美元的贷款本金转换为672,042股普通股,并以无现金方式行使了96,773份认股权证,获得79,330股普通股[237] - 公司与B. Riley Securities和Cantor Fitzgerald签订ATM销售协议,可在未来发行总计不超过6000万美元的普通股[238] - 公司预计未来12个月内将有足够的现金,主要依据收入持续增长、运营效率提高、现金储备、可用融资额度等因素[239]

NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2024, to holders of record at the close of business on July 5, 2024. About LifeMD, Inc. LifeMD is a leading provider of virtual p ...

NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2024, to holders of record at the close of business on July 5, 2024. About LifeMD, Inc. LifeMD is a leading provider of virtual p ...

NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD) today announced the launch of private health insurance acceptance for its virtual primary care services, including weight management for medically qualified patients. Initially available in select states, the company plans to continue enrollments with private payors to facilitate access to medically necessary services, ultimately having broad coverage options across all 50 states. As part of its early 2025 roadmap, LifeMD expects to begi ...

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lotte New York Palace. Justin Schreiber, Chief Executive Officer of LifeMD, will be joining a panel discussion titled “Weight Management/Diabetes Care: Tools to Manage Cost vs Benefit.” Management will also be holding one-on-one m ...